435
Participants
Start Date
April 30, 2009
Primary Completion Date
April 30, 2010
Placebo
Placebo / 12 weeks
Tolterodine
4mg / 12 weeks
ONO-8539
low dose / 12 weeks
ONO-8539
medium dose / 12 weeks
ONO-8539
higher dose / 12 weeks
Brno
Jindřichův Hradec
Olomouc
Opava
Pilsen
Prague
Štětí
Ústí nad Labem
Duisburg
Hagenow
Krumbach
Magdeburg
Mülheim
Weiden
Budapest
Dombóvár
Nyíregyháza
Szeged
Szekszárd
Heerlen
Maastricht
The Hague
Tilburg
Winterswijk
Bialystok
Bielsko-Biala
Gdansk
Gdynia
Katowice
Lodz
Lublin
Mysłowice
Warsaw
Arad
Bihor
Bucharest
Timuș
Moscow
Rostov-on-Don
Saint Petersburg
Gothenburg
Kungälv
Stockholm
Umeå
Uppsala
Chernivtsi
Donetsk
Kharkiv
Kyiv
Zaporizhzhya
Lead Sponsor
Ono Pharmaceutical Co. Ltd
INDUSTRY